|
|
||||||||
1 Department of Population Medicine, University of Guelph, Guelph, Ontario N1G 2W1
2 Provel Division of Eli Lilly Canada Inc., 150 Research Lane, Suite 120, Guelph, Ontario N1G 2T4
3 Université de Montreal, Faculté de médecine vétérinaire, Saint-Hyacinthe, Quebec
4 Department of Health Management, Atlantic Veterinary College, University of PEI, PEI
A total of 1317 Holstein cows from 45 farms in the Canadian provinces of Quebec, Prince Edward Island (PEI) and Ontario were enrolled in a randomized trial during 1998 and 1999 to further confirm the efficacy of a monensin controlled release capsule in preventing periparturient disease in lactating dairy cows. Cows were randomized on the farms to receive either a monensin controlled release capsule (CRC) 2 to 4 wk before expected calving or to serve as negative controls. Health data were collected for 90 d postcalving and were analyzed with logistic regression accounting for the intraherd correlation with generalized estimating equations. Monensin CRC significantly reduced the incidence of both clinical ketosis and abomasal displacement postcalving. There was a numerical but nonsignificant decrease in the incidence of retained placenta in cows receiving a monensin CRC. A pooled analysis of two separate but similar studies (conducted in 1995 and 1998) demonstrated a strengthened association between monensin CRC administration precalving and reduced periparturient disease. A 40% reduction in both abomasal displacement and clinical ketosis was observed with precalving administration of a monensin CRC. In addition, the larger dataset highlighted a trend for a 25% reduction in the incidence of retained placenta in monensin-treated cows. Improved energy metabolism as a result of monensin treatment is likely the mechanism for the reduction in incidence of all three of these diseases. Thus the term "energy associated disease" was created to assess the combined impact of the precalving monensin treatment on the incidence of retained placenta, displaced abomasum, and clinical ketosis. The monensin controlled release capsule reduced the incidence of energy associated disease by 30%.
Key Words: monensin periparturient cow health
Submitted on June 26, 2001
Accepted on October 26, 2001
This article has been cited by other articles:
![]() |
T. F. Duffield, A. R. Rabiee, and I. J. Lean A Meta-Analysis of the Impact of Monensin in Lactating Dairy Cattle. Part 3. Health and Reproduction J Dairy Sci, June 1, 2008; 91(6): 2328 - 2341. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arieli, U. Dicken, I. Dagoni, Y. Spirer, and S. Zamwel Production and Health of Cows Given Monensin Prepartum and a High-Energy Diet Postpartum J Dairy Sci, May 1, 2008; 91(5): 1845 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Karcher, M. M. Pickett, G. A. Varga, and S. S. Donkin Effect of dietary carbohydrate and monensin on expression of gluconeogenic enzymes in liver of transition dairy cows J Anim Sci, March 1, 2007; 85(3): 690 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Loor, H. M. Dann, N. A. J. Guretzky, R. E. Everts, R. Oliveira, C. A. Green, N. B. Litherland, S. L. Rodriguez-Zas, H. A. Lewin, and J. K. Drackley Plane of nutrition prepartum alters hepatic gene expression and function in dairy cows as assessed by longitudinal transcript and metabolic profiling Physiol Genomics, January 12, 2007; 27(1): 29 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. McLaren, K. D. Lissemore, T. F. Duffield, K. E. Leslie, D. F. Kelton, and B. Grexton The Association of Herd Milk Production and Management with a Return-Over-Feed Index in Ontario Dairy Herds J Dairy Sci, January 1, 2005; 88(1): 419 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heuer The Use of Test Day Information to Predict Energy Intake of Dairy Cows in Early Lactation J Dairy Sci, March 1, 2004; 87(3): 593 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Broderick Effect of Low Level Monensin Supplementation on the Production of Dairy Cows Fed Alfalfa Silage J Dairy Sci, February 1, 2004; 87(2): 359 - 368. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |